Testing effectiveness (Phase 2)Study completedNCT05298813
What this trial is testing
Phase 1/2 Study to Evaluate the Efficacy and Safety of Inhaled IBIO123 in Participants With Mild to Moderate COVID-19 Illness
Who this might be right for
COVID-19
Immune Biosolutions Inc 162